Written answers
Wednesday, 18 September 2024
Department of Health
Medicinal Products
Pádraig O'Sullivan (Cork North Central, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
701. To ask the Minister for Health if the HSE will consider the reimbursement of ibrutinib plus venetoclax for patients with chronic lymphocytic leukaemia; and if he will make a statement on the matter. [36428/24]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments